Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury

June 14th 2012

These findings may have clinical relevance particularly in the treatment of diabetes-induced cardiac dysfunction (PLoS ONE)